Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021

Background: Longitudinal surveys to monitor the seroprevalence are required to support efforts for assessment of the levels of endemic stability in certain countries. We investigated seroprevalence of anti-SARS-CoV-2-S1 receptor-binding domain (RBD)-specific antibodies in the serum samples in 2011–2...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumanova, Nadezhda G., Gorshkov, Alexander U., Bogdanova, Natalya L., Korolev, Andrew I., Drapkina, Oxana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032149/
https://www.ncbi.nlm.nih.gov/pubmed/35455330
http://dx.doi.org/10.3390/vaccines10040581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032149/
https://www.ncbi.nlm.nih.gov/pubmed/35455330
http://dx.doi.org/10.3390/vaccines10040581

Ejemplares similares